What’s the Best Chemotherapy Strategy in Ovarian Cancer?
January 30, 2017 9:41 pmResults from the Gynecologic Oncology Group (GOG) 252 trial, while highly anticipated in the oncology community, did not give any additional clarity for the use of intravenous (IV) versus intraperitoneal (IP) chemotherapy for patients with ovarian cancer, says Franco M. … Read more